PRICESMART INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data PRICESMART INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	2,997	3,167	3,224	3,329	3,620	4,066	4,412	4,914	5,270	5,876
Cost of revenue	2,520	2,657	2,696	2,775			3,653	4,067	4,356	4,838
Gross profit	477	510	528	554			759	847	914	1,038
General and administrative	70	88.5	101	107	125	133	135	156	180	209
Operating income	136	126	115	122	158	167	185	221	233	261
Interest expense	6.78	5.07	3.94	7.63	7.21	9.61	11	13	11.5	16.8
Interest income	1.81	1.42	1.49	2.03	1.98	2.2	9.87	11	10.1	13.1
Other non-operating income	1.48	0.19	-1.61	-0.83	-5.6	-3.24	-14.2	-17.6	-24.6	-29.7
Pre-tax income	133	123	111	116	147	156	169	0.1	206	228
Income tax	42	48.2	37.6	37.8	49	51.9	60	62.6	58.6	61.1
Income from continuing operations	90.7	74.3
Net income to minority interests		0.08	0.3	0.07	0.2	0.02	0	0
Net income	90.7	74.3	73.2	78.1	98	105	109	139	148	167
EBITDA	183	179	170	184	223	235	257	304	321	361
EPS, basic	2.98	2.44	2.40	2.55	3.18	3.38	3.51	4.57	4.82	5.40
EPS, diluted	2.98	2.44	2.40	2.55	3.18	3.38	3.50	4.57	4.82	5.40
Shares, basic (weighted)	30	30.1	30.2	30.3	30.4	30.6	30.8	30	30.1	30.2
Shares, diluted (weighted)	30	30.1	30.2	30.3	30.4	30.6	30.8	30	30.1	30.2
Dividend per share	0.70	0.70	0.70	0.70	0.70	0.86	0.92	2.16	1.26	1.40

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	162	93.5	103	299	202	238	240	125	241	221
Short-term investments		32.3	17	46.5	50.2	11.2	91.1	100	73.2	111
Receivables	6.46	8.86	9.87	13.2	12.4	13.4	17.9	18.8	17.4	16.6
Inventory	311	321	331	310	390	464	471	529	561	617
Other current assets	30.1	31.8	31	30.2	39.2	43.9	53.9	57.9	71.1	80
Total current assets	510	488	492	699	697	774	877	832	974	1,059
Property, plant and equipment	558	594	671	692	730	757	850	936	996	1,183
Lease right-of-use assets				120	124	112	114	96.4	113	129
Goodwill	35.6	46.3	46.1	45.2	45.1	43.3	43.1	43.2	43.2	43.3
Intangible assets		15	12.6	10.2	7.76	0.77
Other non-current assets	44.7	48.9	45	54.3	57.3	72.9	69	61.6	60.4	98.5
Total assets	1,178	1,216	1,296	1,657	1,706	1,808	2,006	2,023	2,269	2,603
Accounts payable	272	256	286	373	389	408	453	486	507	559
Accrued liabilities	19.2	22.8	25.4	32.9	41.9	44.1	45.4	48.3	52.5	64.1
Deferred revenue	22.1	23	25.3	23.5	26.9	29.2	32.6	38.1	43.1	52.2
Short-term debt	18.4	14.9	25.9	19.4	19.4	33.7	20.2	35.9	38.7	64.6
Total current liabilities	363	349	407	568	534	579	634	680	726	855
Long-term debt	87.9	87.7	63.7	113	110	104	119	94.4	148	103
Lease liabilities				124	129	118	122	104	122	139
Other non-current liabilities		5.27	8.69	12.2	10.9	8.44	15.4	14.8	20.9	48.1
Total liabilities	469	458	498	824	790	817	899	900	1,022	1,148
Total debt	106	103	89.6	132	130	137	140	130	187	168
Paid-in capital	422	433	443	454	465	481	497	515	529	549
Retained earnings	421	474	526	582	659	737	818	890	999	1,123
Treasury stock	-35.9	-39.1	-38.7	-28.4	-26.1	-31.6	-44	-117	-120	-126
Other comprehensive income	-110	-121	-144	-177	-183	-196	-164	-165	-161	-91.3
Shareholders' equity	709	758	797	832	915	991	1,107	1,123	1,247	1,455
Minority interests		0.64	0.93	1.01	0.87
Total equity	709	759	798	833	916	991	1,107	1,123	1,247	1,455
Total liabilities and equity	1,178	1,216	1,296	1,657	1,706	1,808	2,006	2,023	2,269	2,603
Shares outstanding	30.4	30.5	30.5	30.7	30.8	30.9	31	30.6	30.7	30.9

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	90.7	74.4	73.5	78.2	98.2	105	109	139	148	167
Depreciation and amortization	46.3	52.6	55	61.2	65	67.9	72.7	82.6	88.2	99.5
Stock-based compensation	9.69	10.2	15.1	13.8	18.4	16.8	16.6	17.3	18.8	23.3
Deferred income tax	-2.85	6.96	-2.99	-3.4	-3.85	-3.3	-3.29	-4.08	-4.18	-9.38
Change in inventory	-28	-10.1	-10.2	21.8	-80.2	-74.7	-10.2	-57.3	-32.1	-57.5
Change in payables	3.34	-16.5	25.3	90.2	15.5	23.1	43.4	32.5	25	47
Cash from operations	123	119	170	259	127	122	257	208	261	308
Capital expenditures	-135	-98.1	-140	-100	-113	-121	-143	-169	-158	-211
Acquisitions		-23.9
Purchases of investments						-22.5	-139	-184	-79.6	-174
Cash from investing	-135	-154	-125	-131	-117	-74.8	-222	-175	-129	-254
Debt issued	47.7	28.5		57.9	17.6	30.6	38.7	16.5	92.9	20.8
Debt repaid	-29.4	-32.1	-12.9	-15.2	-20	-22.7	-36	-26.3	-37.4	-40
Stock issued	0.7	0.27
Share buybacks						-6.26	-12.9	-73.5	-6.71	-9.09
Dividends paid	-21.3	-21.2	-21.7	-21.5	-22	-26.6	-28.5	-66.2	-38.7	-43
Cash from financing	-22	-27.8	-32	75.6	-95.1	-12.2	-41.1	-150	14.2	-82
Exchange rate effect	-2.84	-6.66	-4.35	-6.08	-3.6	1.03	6.64	2	2.36	7.42
Net change in cash	-37	-68.8	9.32	198	-88.3	35.9	0.83	-116	149	-20.6
Free cash flow	-12.3	21.3	30.3	159	14	1.17	115	39	103	96.4
Interest paid	3.77	4.96	3.5	6.88	7.77	9.39	10.6	13.3	11	11.6
Income taxes paid	44.3	52.2	48.3	50.8	58.6	67.1	77.9	90.6	83.7	106

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $165.91 on November 9, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	17.7%	Gross profit / revenue.
Operating margin	4.4%	Operating income / revenue.
EBITDA margin	6.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.9%	Pre-tax income / revenue.
Net margin	2.8%	Net income / revenue.
FCF margin	1.6%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.2%	Cash from operations / revenue.
Effective tax rate	26.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	12.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.8%	Net income / average total assets.
Return on invested capital (ROIC)	14.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.6%	Capital expenditures / revenue.
D&A / revenue	1.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	11.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	10.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	13.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	11.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income growth, 1y	12.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	12.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	10.6%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	12.4%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	11.9%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	10.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	12.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	15.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	11.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	12.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	15.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	11.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	17.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	6.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	19.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-6.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-5.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	47.1%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	11.1%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	15.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	14.9%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	16.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	9.5%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	14.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	9.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.24x	Current assets / current liabilities.
Quick ratio	0.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.39x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.12x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	6.4%	Total debt / total assets.
Liabilities / assets	44.1%	Total liabilities / total assets.
Net debt	-$164.7M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.46x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	15.6x	Operating income / interest expense.
Working capital	$204.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	1.7%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.41B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	2.41x	Revenue / average total assets.
Fixed asset turnover	5.39x	Revenue / average property, plant and equipment.
Inventory turnover	8.21x	Cost of revenue / average inventory.
Days inventory	44 days	365 x average inventory / cost of revenue.
Receivables turnover	345x	Revenue / average receivables.
Days sales outstanding	1 days	365 x average receivables / revenue.
Days payables	40 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	5 days	Days inventory + days sales outstanding - days payables.
FCF conversion	57.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	68.7%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.40	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$5.40	Net income per basic share, as reported (split-adjusted).
Revenue per share	$194.30	Revenue / diluted weighted shares.
FCF per share	$3.19	Free cash flow / diluted weighted shares.
Operating cash flow per share	$10.18	Cash from operations / diluted weighted shares.
Book value per share	$47.17	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$45.76	Tangible book value / shares outstanding.
Cash per share	$10.77	(Cash + short-term investments) / shares outstanding.
Dividend per share	$1.40	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	25.8%	Dividends paid / net income, when net income is positive.
Dividends / FCF	44.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	9.4%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.12B	Share price x shares outstanding.
Enterprise value	$4.96B	Market cap + total debt - cash - short-term investments.
P/E	30.7x	Market cap / net income. Only when net income is positive.
P/S	0.87x	Market cap / revenue.
P/B	3.52x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.63x	Market cap / tangible book value, when positive.
P/FCF	53.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	16.6x	Market cap / cash from operations, when positive.
EV/Sales	0.84x	Enterprise value / revenue.
EV/EBIT	19.0x	Enterprise value / operating income, when both are positive.
EV/EBITDA	13.7x	Enterprise value / EBITDA, when both are positive.
EV/FCF	51.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.9%	Free cash flow / market cap.
Earnings yield	3.3%	Net income / market cap (the inverse of P/E).
Dividend yield	0.8%	Dividends paid over the period / market cap.
Shareholder yield	1.0%	(Dividends paid + share buybacks) / market cap.
PEG	1.98x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was PRICESMART INC's revenue in fiscal 2026?

PRICESMART INC reported revenue of $5.88B for fiscal 2026, 11.5% higher than the year before.

Was PRICESMART INC profitable in fiscal 2026?

Yes. Net income was $166.6M, a net margin of 2.8%.

How much free cash flow did PRICESMART INC generate in fiscal 2026?

Cash from operations of $307.7M minus capital expenditures of $211.3M left free cash flow of $96.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to PRICESMART INC